HeartBeam Past Earnings Performance
Past criteria checks 0/6
HeartBeam's earnings have been declining at an average annual rate of -55.7%, while the Medical Equipment industry saw earnings growing at 11.1% annually.
Key information
-55.7%
Earnings growth rate
-24.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | n/a |
| Return on equity | -120.5% |
| Net Margin | n/a |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Companies Like HeartBeam (NASDAQ:BEAT) Could Be Quite Risky
Jan 17
HeartBeam gets a new chief medical officer
Oct 11HeartBeam gets patent to enable generation of its credit card-sized ECG, shares rise ~15%
Sep 28HeartBeam surges 54% on U.S. patent for ECG patch monitor to detect heart attacks
Sep 15HeartBeam GAAP EPS of $0.43 beats by $0.70
Aug 11HeartBeam: Cardiovascular Diagnostics On The Go
Dec 14Revenue & Expenses BreakdownBeta
How HeartBeam makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 0 | -15 | 8 | 8 |
| 31 Dec 23 | 0 | -15 | 9 | 7 |
| 30 Sep 23 | 0 | -14 | 9 | 6 |
| 30 Jun 23 | 0 | -15 | 8 | 6 |
| 31 Mar 23 | 0 | -15 | 8 | 7 |
| 31 Dec 22 | 0 | -13 | 7 | 6 |
| 30 Sep 22 | 0 | -11 | 7 | 4 |
| 30 Jun 22 | 0 | -9 | 5 | 3 |
| 31 Mar 22 | 0 | -6 | 3 | 1 |
| 31 Dec 21 | 0 | -4 | 2 | 0 |
| 30 Sep 21 | 0 | -3 | 1 | 0 |
| 30 Jun 21 | 0 | -2 | 1 | 0 |
| 31 Mar 21 | 0 | -1 | 1 | 0 |
| 31 Dec 20 | 0 | -1 | 1 | 0 |
Quality Earnings: BEAT is currently unprofitable.
Growing Profit Margin: BEAT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BEAT is unprofitable, and losses have increased over the past 5 years at a rate of 55.7% per year.
Accelerating Growth: Unable to compare BEAT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BEAT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).
Return on Equity
High ROE: BEAT has a negative Return on Equity (-120.51%), as it is currently unprofitable.